Summary
Depression is one of the most common reversible psychiatric disorders in the medically ill hospitalised elderly. Because of its adverse impact on quality of life, compliance with medical therapy, motivation towards recovery, and survival itself, depression requires rapid diagnosis and comprehensive management. Because of the risks attendant on the use of antidepressants and electroconvulsive therapy (ECT) in this population, medical and psychosocial strategies are of paramount and primary importance in the treatment of most critically ill depressed elderly individuals. These include adequate treatment of reversible medical illness, provision of psychological support, mobilisation of community resources, and involvement of family and social support networks. When depression is severe or associated with marked suicidal ideation, however, these four strategies may need to be carried out concurrently with biological therapies.
After ensuring adequate cardiac, liver, and renal function, antidepressant therapy is best initiated at a low dosage (secondary amine preferred) and gradually titrated upward following serum concentrations carefully and monitoring for anticholinergic, hypotensive and cardiac adverse effects. If antidepressant therapy is not tolerated or is unsuccessful, then psychiatric consultation should be obtained and ECT considered, particularly if the patient is well enough to undergo repeated episodes of brief general anaesthesia.
Similar content being viewed by others
References
Altamura AC, Mauri MC, Rudas N, Carpiniello B, Montanini R, et al. Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlled multicenter trial. Clinical Neuropharmacology 12 (Suppl. 1): S25–33, S34-37, 1989
Aronson MD, Hafez H. A case of trazodone-induced ventricular tachycardia. Journal of Clinical Psychiatry 47: 388–389, 1986
Askinazi L, Weintraub RJ, Karamouz N, et al. Elderly depressed females as a possible subgroup of patients responsive to methylphenidate. Journal of Clinical Psychiatry 47: 467–469, 1986
Benfield P, Heel RC, Lewis SP. Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32: 481–508, 1986
Bouchard RH, Pourcher E, Vincent P. Fluoxetine and extrapyramidal side effects. American Journal of Psychiatry 146: 1352–1353, 1989
Chan CH, Ruskiewicz RJ. Anticholinergic side effects of trazadone combined with another pharmacologic agent. American Journal of Psychiatry 147: 533, 1990
Davidson J. Seizures and bupropion: a review. Journal of Clinical Psychiatry 50: 256–261, 1989
Fawzy IF, Cousins N, Fawzy NW, Kemeny ME, Elashoff R, et al. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Archives of General Psychiatry 47: 720–725, 1990
Gaspar D, Samarasinghe LA. ECT in psychogeriatric practice: a study of risk factors, indications and outcome. Comprehensive Psychiatry 23: 170–175, 1982
Goldberg EL, Van Natta P, Comstock GW. Depressive symptoms, social networks, and social suport of elderly women. American Journal of Epidemiology 121: 448–456, 1985
Golden RN, James SP, Sherer MA, Rudorfer MV, Sack DA, et al. Psychoses associated with bupropion treatment. American Journal of Psychiatry 142: 1459–1462, 1985
Hardy B, Shulman K, MacKenzie S, Kutcher SP, Silverberg JD. Pharmacokinetics of lithium in the elderly. Journal of Clinical Psychopharmacology 7: 153–158, 1987
Idler EL, Kasl SV. Religion, disability, depression, and the timing of death. American Journal of Sociology, in press, 1991
Jarvik LF, Mintz J, Steuer J, Gerner R. Treating geriatric depression: a 26-week interim analysis. Journal of the American Geriatric Society 30: 713–717, 1982
Katon W, Raskind M. Treatment of depression in medically ill elderly with methylphenidate. American Journal of Psychiatry 137: 963–965, 1980
Koenig HG. Shepherds’ Centers: elderly people helping themselves. Journal of the American Geriatric Society 34: 73, 1986
Koenig HG. Electroconvulsive therapy for treatment of depression in older patients. Geriatric Consultant 1(5): 14–16, 1991
Koenig HG, Blazer DG. Affective disorders. In Cassel CK et al. (Eds) Geriatric medicine, 2nd ed., pp. 473–490, Springer-Verlag, New York, 1990
Koenig HG, Blazer DG. Mood disorders and suicide. In Birren JE (Ed.) Handbook of mental health and aging, Academic Press, in press, 1991
Koenig HG, Breitner J. Antidepressant use in the medically ill older person. Psychosomatics 31: 22–32, 1990
Koenig HG, Goli V, Shelp F, Kudler HS, Cohen HJ, et al. Antidepressant use in older medically ill inpatients: lessons from an attempted clinical trial. Journal of General Internal Medicine 4: 498–505, 1989a
Koenig HG, Kvale JN, Ferrel C. Religion and well-being in later life. Gerontologist 28: 18–28, 1988a
Koenig HG, Meador KM, Cohen HJ, Blazer D. Detection and treatment of major depression in the older hospitalized patient with medical illness. International Journal of Psychiatry in Medicine 18: 17–31, 1988
Koenig HG, Meador K, Cohen HJ, Blazer D. Depression in elderly men hospitalized with medical illness. Archives of Internal Medicine 148: 1929–1936, 1988b
Koenig HG, Meador KG, Shelp F, Goli V, Cohen HJ, et al. Major depressive disorder in hospitalized medically ill patients: an examination of young and elderly patients. Journal of the American Geriatrics Society, in press, 1991
Koenig HG, Shelp F, Goli V, Cohen HJ, Blazer DG. Survival and healthcare utilization in elderly medical inpatients with major depression. Journal of American Geriatric Society 37: 599–606, 1989b
Koenig HG, Smiley M, Gonzales J. Religion, health and aging, Greenwood Press, Westport, Conn., 1988c
Koenig HG, Studenski S. Post-stroke depression in the elderly. Journal of General Medicine 3: 508–517, 1988
Lakshmanan M, Mion LC, Frengley JD. Effective low dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients. Journal of the American Geriatric Society 34: 421–426, 1986
Lipinski JF, Mallya G, Zimmerman P, Pope HG. Fluoxetine-induced akathisia: clinical and theoretical implications. Journal of Clinical Psychiatry 50: 339–342, 1989
Lipsey JR, Robinson RG, Pearlson GD. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1: 297–300, 1984
Miller F, Whitcup S. Benzodiazepine use in psychiatrically hospitalized elderly patients. Journal of Clinical Psychopharmacology 6: 384–385, 1986
Murphy E. Social origins of depression in old age. British Journal of Psychiatry 141: 135–142, 1982
Patterson BD, Srisopark MM. Severe anorexia and possible psychosis or hypomania after trazodone-tryptophan treatment of agression. Lancet 1: 1017, 1989
Pinner E, Rich CL. Effects of trazadone on aggressive behavior in seven patients with organic mental disorders. American Journal of Psychiatry 145: 1295–1296, 1988
Pressman P, Lyons JS, Larson DB, Strain JJ. Religious belief, depression, and ambulation status in elderly women with broken hips. American Journal of Psychiatry 147: 758–760, 1990
Rapp SR, Walsh DA, Parisi SA, Wallace CE. Detecting depression in elderly medical inpatients. Journal of Consulting and Clinical Psychology 56: 509–514, 1988
Reding MJ, Orto LA, Winter SW, Forturna IM, Di Ponte P, et al. Antidepressant therapy after stroke: a double-blind trial. Archives of Neurology 43: 763–768, 1986
Regestein QR, Reich P. Electroconvulsive therapy in patients at high risk for physical complications. Convulsive Therapy 1: 101–114, 1985
Reifler BV, Teri L, Raskind M, Veith R, Barnes R, et al. Doubleblind trial of imipramine in Alzheimer’s Disease patients with and without depression. American Journal of Psychiatry 146: 45–49, 1989
Rudorfer MV, Manji HK, Potter WZ. The new-generation anti-depressants: Part 3: Bupropion and medications under development. Hospital Therapy 15: 911–928, 1990
Schatzberg AF, Cole JO. Benzodiazepines in depressive disorder. Archives of General Psychiatry 35: 1359–1365, 1978
Schulberg HC, McClelland M, Gooding W. Six-month outcomes for medical patients with major depressive disorders. Journal of General Internal Medicine 2: 312–317, 1987
Shopsin B, Cassano GB, Conti L. An overview of new ‘second generation’ antidepressant compounds: research and treatment implications. In Enna et al. (Eds) Antidepressants: neurochemical, behavioral and clinical perspectives, pp. 219–245, Raven Press, New York, 1981
Stack JA, Reynolds CF, Perel JM, Houck PR, Hoch CC, et al. Pretreatment systolic orthostatic blood pressure and treatment response in elderly depressed inpatients. Journal of Clinical Psychopharmacology 8: 116–120, 1988
Sternbach H. Danger of MAOI therapy after fluoxetine withdrawal. Correspondence. Lancet 2: 850–851, 1988
Teasdale JD, Fennel MJV, Hibbert GA, Amies PL. Cognitive therapy for major depressive disorder in primary care. British Journal of Psychiatry 144: 400–406, 1984
Tobin SS, Ellor J, Anderson-Ray SM. Enabling the elderly: religious institutions within the community service system, State University of New York Press, Albany, 1986
Uhlenhuth EH, Balter MB, Mellinger GD, Cisin IH, Clinthorne J, et al. Symptom checklist of syndromes in the general population: correlations with psychotherapeutic drug use. Archives of General Psychiatry 40: 1167–1173, 1983c
Weiner RD, Coffey CE. ECT in the medically ill. In Stoudemire & Fogel (Eds) Principles of medical psychiatry, pp. 113–134, Grune & Stratton Inc., 1987
Wernicke JF, Dunlop SR, Dornseif BE, Bosomworth JC, Humbert M. Low-dose fluoxetine therapy for depression. Psychopharmacology Bulletin 24: 183–188, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koenig, H.G. Treatment Considerations for the Depressed Geriatric Medical Patient. Drugs & Aging 1, 266–278 (1991). https://doi.org/10.2165/00002512-199101040-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199101040-00003